Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: Hypoxia and angiopoietin-2

Breast Cancer Research

Volumn 9, Issue 3, 2007, Pages

  Lewis, Claire E ^a   Hughes, Russell ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2;

ARTICLE; BREAST TUMOR; CELL HYPOXIA; DISEASE COURSE; FEMALE; HOMEOSTASIS; HUMAN; INFLAMMATION; MACROPHAGE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; BREAST NEOPLASMS; CELL HYPOXIA; DISEASE PROGRESSION; FEMALE; HOMEOSTASIS; HUMANS; INFLAMMATION; MACROPHAGES; NEOVASCULARIZATION, PATHOLOGIC;

EID: 34548545297     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1679     Document Type: Review

References (32)

1. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001, 193:727-740. 10.1084/jem.193.6.727, 11257139.
2. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002, 196:254-265. 10.1002/path.1027, 11857487.
3. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006, 66:605-612. 10.1158/0008-5472.CAN-05-4005, 16423985.
4. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue XN, Pollard JW. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 2006, 66:11238-11246. 10.1158/0008-5472.CAN-06-1278, 17114237.
5. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996, 56:4625-4629.
6. O'Sullivan C, Lewis CE, Harris AL, McGee JO. Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet 1993, 342:148-149. 10.1016/0140-6736(93)91348-P, 8101258.
7. Lewis JS, Landers RJ, Underwood JC, Harris AL, Lewis CE. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol 2000, 192:150-158. 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G, 11004690.
8. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 2006, 25:315-322. 10.1007/s10555-006-9001-7, 16967326.
9. Sica A, Saccani A, Bottazzi B, Polentarutti N, Vecchi A, van Damme J, Mantovani A. Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation in tumor-associated macrophages. J Immunol 2000, 164:762-767.
10. Vaupel P, Schlenger K, Knoop C, Hockel M. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 1991, 51:3316-3322.
11. Holmquist L, Lofstedt T, Pahlman S. Effect of hypoxia on the tumor phenotype: the neuroblastoma and breast cancer models. Adv Exp Med Biol 2006, 587:179-193.
12. Leek RD, Landers RJ, Harris AL, Lewis CE. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999, 79:991-995. 10.1038/sj.bjc.6690158, 10070902.
13. Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004, 104:2224-2234. 10.1182/blood-2004-03-1109, 15231578.
14. Turner L, Scotton C, Negus R, Balkwill F. Hypoxia inhibits macrophage migration. Eur J Immunol 1999, 29:2280-2287. 10.1002/(SICI)1521-4141(199907)29:07<2280::AID-IMMU2280>3.0.CO;2-C, 10427991.
15. Burke B, Giannoudis A, Corke KP, Gill D, Wells M, Ziegler-Heitbrock L, Lewis CE. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol 2003, 163:1233-1243. 1868302, 14507633.
16. Bingle L, Lewis CE, Corke KP, Reed MW, Brown NJ. Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer 2006, 94:101-107. 10.1038/sj.bjc.6602901, 16404363.
17. White JR, Harris RA, Lee SR, Craigon MH, Binley K, Price T, Beard L, Mundy CR, Naylor S. Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis. Genomics 2004, 83:1-8. 10.1016/S0888-7543(03)00215-5, 14667803.
18. Lewis C, Murdoch C. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am J Pathol 2005, 167:627-635. 1698733, 16127144.
19. Burke B, Tang N, Corke KP, Tazzyman D, Ameri K, Wells M, Lewis CE. Expression of HIF-1α by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J Pathol 2002, 196:204-212. 10.1002/path.1029, 11793372.
20. Leek RD, Talks KL, Pezzella F, Turley H, Campo L, Brown NS, Bicknell R, Taylor M, Gatter KC, Harris AL. Relation of hypoxia-inducible factor-2α (HIF-2α) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in human breast cancer. Cancer Res 2002, 62:1326-1329.
21. Elbarghati L, Murdoch C, Lewis CE. Expression of hypoxia-inducible transcription factors by human macrophages: involvement of HIF-1 in the hypoxic induction of VEGF and mmP-7. J Leukoc Biol 2005, (Suppl):19-79.
22. Oda T, Hirota K, Nishi K, Takabuchi S, Oda S, Yamada H, Arai T, Fukuda K, Kita T, Adachi T, et al. Activation of hypoxia-inducible factor 1 during macrophage differentiation. Am J Physiol Cell Physiol 2006, 291:C104-C113. 10.1152/ajpcell.00614.2005, 16481368.
23. Konur A, Kreutz M, Knuchel R, Krause SW, Andreesen R. Three-dimensional co-culture of human monocytes and macrophages with tumor cells: analysis of macrophage differentiation and activation. Int J Cancer 1996, 66:645-652. 10.1002/(SICI)1097-0215(19960529)66:5<645::AID-IJC11>3.0.CO;2-3, 8647627.
24. Tait CR, Jones PF. Angiopoietins in tumours: the angiogenic switch. J Pathol 2004, 204:1-10. 10.1002/path.1618, 15307132.
25. Tsutsui S, Inoue H, Yasuda K, Suzuki K, Takeuchi H, Nishizaki T, Higashi H, Era S, Mori M. Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density. Breast Cancer Res Treat 2006, 98:261-266. 10.1007/s10549-005-9157-9, 16538528.
26. Kuliszewska K, Maisonpierre PC, Jones N, Campbell AI, Master Z, Bendeck MP, Alitalo K, Dumont DJ, Yancopoulos GD, Stewart DJ. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res 2001, 49:659-670. 10.1016/S0008-6363(00)00231-5, 11166279.
27. De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M, Naldini L. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005, 8:211-226. 10.1016/j.ccr.2005.08.002, 16169466.
28. Venneri MA, De Palma M, Ponzoni M, Pucci F, Scielzo C, Zonari E, Mazzieri R, Doglioni C, Naldini L. Identification of pro-angiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood
29. Murdoch C, Tazzyman S, Webster S, Lewis CE. Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J Immunol 2007, 178:7405-7411.
30. Krikun G, F Schatz T, Finlay S, Kadner A, Mesia R, Gerrets H, Lockwood CJ. Expression of angiopoietin-2 by human endometrial endothelial cells: regulation by hypoxia and inflammation. Biochem Biophys Res Commun 2000, 275:159-163. 10.1006/bbrc.2000.3277, 10944458.
31. Balkwill FR. Tumour necrosis factor and cancer. Prog Growth Factor Res 1992, 4:121-137. 1338573, 10.1016/0955-2235(92)90027-F.
32. Kim I, Kim JH, Ryu YS, Liu M, Koh GY. Tumor necrosis factor-α up-regulates angiopoietin-2 in human umbilical vein endothelial cells. Biochem Biophys Res Commun 2000, 269:361-365. 10708557, 10.1006/bbrc.2000.2296.